5.5599
price down icon5.14%   -0.2801
 
loading

Scpharmaceuticals Inc Stock (SCPH) Forecast

The Scpharmaceuticals Inc (SCPH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.9376, representing a +60.75% increase from the current price of $5.5599. The highest analyst price target is $9.7145, and the lowest is $8.1607.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SCPH Price Target
Average 8.5338 (+53.49% Upside)
loading

Is Scpharmaceuticals Inc (SCPH) A Buy Now?

Oscillators
Name Value Action
RSI(14) 77.53 Sell
STOCH(9,6) 87.26 Sell
STOCHRSI(14) 75.49 Neutral
MACD(12,26) 0.4616 Buy
ADX(14) 50.76 Buy
William %R -25.59 Neutral
CCI(14) 107.04 Buy
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
5.0585
Buy
5.1495
Buy
MA20
4.5473
Buy
4.7513
Buy
MA50
4.0542
Buy
4.1436
Buy
MA100
3.3594
Buy
3.7647
Buy
MA200
3.4953
Buy
3.748
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, SCPH could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on SCPH, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 77.53 indicates that SCPH is overbought. This suggests that SCPH price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 87.26 indicates that SCPH is oversold. This means that SCPH price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 75.49 indicates that SCPH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 50.76 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 107.04 indicates that SCPH is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term SCPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Scpharmaceuticals Inc financial reports and earnings history, Scpharmaceuticals Inc (SCPH) stock could reach $5.9723 by 2030, $15.68 by 2040 and $11.91 by 2050. See the projected annual prices until 2050 of the Scpharmaceuticals Inc stock below:

  • Scpharmaceuticals Inc (SCPH) is expected to reach an average price of $8.55 in 2035, with a high prediction of $8.705 and a low estimate of $7.3954. This indicates an $53.78% rise from the last recorded price of $5.5599.
  • Scpharmaceuticals Inc (SCPH) stock is projected to chart a bullish course in 2040, with an average price target of $13.90, representing an $149.97% surge from its current level. The forecast ranges from a conservative $12.64 to a sky-high $15.68.
  • Our analysts predict Scpharmaceuticals Inc (SCPH) to jump 83.69% by 2045, soaring from $9.679 to an average price of $10.21, potentially reaching $12.03. While $9.679 is the low estimate, the potential upside is significant.
  • Scpharmaceuticals Inc (SCPH) stock is expected to climb by 2050, reaching an average of $11.64, a $109.39% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.91 and $10.87, respectively, highlighting the market's uncertainty.

Scpharmaceuticals Inc Stock (SCPH) Year by Year Forecast

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2025

Scpharmaceuticals Inc Stock (SCPH) is expected to reach an average price of $9.1383 in 2025, with a high prediction of $13.14 and a low estimate of $5.139. This indicates an +64.36% rise from the last recorded price of $5.5599.
Month Average Low High Change from today's price
August, 2025 $8.788 $8.1607 $9.7145 +58.06%
September, 2025 $8.9526 $8.2591 $9.2591 +61.02%
October, 2025 $9.4183 $8.9183 $10.35 +69.40%
November, 2025 $8.6229 $8.1217 $9.9194 +55.09%
December, 2025 $9.7986 $8.3552 $10.53 +76.24%

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2026

The predicted value for Scpharmaceuticals Inc (SCPH) in 2026 is set at an average of $8.4006. Estimates vary from a peak of $10.82 to a trough of $5.9802, indicating an +51.09% surge from the present price of $5.5599.
Month Average Low High Change from today's price
January, 2026 $10.28 $9.5148 $10.82 +84.95%
February, 2026 $6.9778 $6.2466 $10.63 +25.50%
March, 2026 $7.2824 $6.4001 $7.7612 +30.98%
April, 2026 $8.6781 $7.3535 $8.76 +56.08%
May, 2026 $8.3127 $7.5692 $9.3992 +49.51%
June, 2026 $7.7173 $7.51 $8.4688 +38.80%
July, 2026 $6.963 $6.6775 $8.8684 +25.24%
August, 2026 $6.9376 $6.7464 $7.3842 +24.78%
September, 2026 $7.4633 $6.3387 $8.5022 +34.23%
October, 2026 $6.6979 $6.3668 $8.0645 +20.47%
November, 2026 $7.5025 $5.9802 $7.7214 +34.94%
December, 2026 $7.8616 $6.9448 $8.4771 +41.40%

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Scpharmaceuticals Inc (SCPH) is $6.4207, with a high forecast of $8.1105 and a low forecast of $4.7308. This indicates an +15.48% increase from the last price of $5.5599.
Month Average Low High Change from today's price
January, 2027 $7.6628 $7.2028 $8.1105 +37.82%
February, 2027 $5.9374 $5.9174 $7.7363 +6.79%
March, 2027 $6.1031 $4.7308 $6.4031 +9.77%
April, 2027 $5.3477 $5.3379 $7.1043 -3.82%
May, 2027 $6.5423 $4.94 $6.6623 +17.67%
June, 2027 $6.438 $6.0158 $7.1408 +15.79%
July, 2027 $6.9526 $5.7903 $7.4907 +25.05%
August, 2027 $6.3472 $6.0372 $8.0738 +14.16%
September, 2027 $6.083 $5.3384 $6.5294 +9.41%
October, 2027 $5.5875 $5.3075 $6.3952 +0.50%
November, 2027 $6.3421 $5.6187 $6.532 +14.07%
December, 2027 $7.4479 $5.9967 $7.4479 +33.96%

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2028

In 2028, Scpharmaceuticals Inc (SCPH) is projected to reach an average price of $9.5438, with a high projection of $14.10 and a low estimate of $4.9893. This indicates an +71.65% rise from the last price of $5.5599.
Month Average Low High Change from today's price
January, 2028 $7.1424 $6.9144 $7.812 +28.46%
February, 2028 $7.827 $5.7647 $7.907 +40.78%
March, 2028 $6.6528 $4.9893 $8.1082 +19.66%
April, 2028 $8.8474 $6.6039 $9.0774 +59.13%
May, 2028 $7.5131 $7.2308 $9.2785 +35.13%
June, 2028 $7.6677 $7.3442 $8.6454 +37.91%
July, 2028 $9.1023 $6.8288 $9.7217 +63.71%
August, 2028 $8.158 $7.938 $11.71 +46.73%
September, 2028 $10.56 $7.8491 $10.79 +89.98%
October, 2028 $12.53 $10.17 $13.04 +125.31%
November, 2028 $12.35 $11.39 $14.10 +122.18%
December, 2028 $11.55 $10.93 $13.10 +107.69%

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2029

The 2029 price forecast for Scpharmaceuticals Inc Stock (SCPH) is $8.3703 on average, with a high prediction of $11.45 and a low estimate of $5.29. This represents an +50.55% increase from the previous price of $5.5599.
Month Average Low High Change from today's price
January, 2029 $9.7932 $9.3722 $11.45 +76.14%
February, 2029 $9.3078 $8.5467 $9.9155 +67.41%
March, 2029 $8.3924 $8.2724 $9.349 +50.95%
April, 2029 $7.587 $7.257 $8.9235 +36.46%
May, 2029 $6.2927 $6.0127 $7.6481 +13.18%
June, 2029 $6.8773 $6.0739 $7.32 +23.69%
July, 2029 $7.6619 $6.3484 $8.1007 +37.81%
August, 2029 $6.2976 $6.2976 $7.993 +13.27%
September, 2029 $7.0622 $6.1399 $7.4361 +27.02%
October, 2029 $6.5779 $6.3569 $7.9434 +18.31%
November, 2029 $5.9725 $5.6625 $6.7402 +7.42%
December, 2029 $5.62 $5.29 $6.2037 +1.08%

Scpharmaceuticals Inc Stock (SCPH) Price Forecast for 2030

Scpharmaceuticals Inc Stock (SCPH) is expected to reach an average price of $9.0848 in 2030, with a high forecast of $13.21 and a low forecast of $4.9561. This signifies an +63.40% surge from the last price of $5.5599.
Month Average Low High Change from today's price
January, 2030 $5.5715 $5.3628 $5.9723 +0.21%
February, 2030 $5.8056 $4.9561 $5.9806 +4.42%
March, 2030 $7.4748 $5.7929 $8.2875 +34.44%
April, 2030 $8.664 $7.3121 $8.8667 +55.83%
May, 2030 $8.0555 $7.5882 $9.8536 +44.88%
June, 2030 $7.8296 $7.3027 $8.6773 +40.82%
July, 2030 $6.7711 $6.4311 $8.1765 +21.78%
August, 2030 $6.9203 $6.2434 $7.9003 +24.47%
September, 2030 $8.1094 $7.0926 $8.5294 +45.86%
October, 2030 $10.71 $7.6263 $10.74 +92.65%
November, 2030 $9.1701 $7.9751 $13.21 +64.93%
December, 2030 $10.46 $7.2747 $11.52 +88.12%
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Cap:     |  Volume (24h):